Photovoltaic Cell Containing Novel Photoactive Polymer

ABSTRACT

Novel photoactive polymers, as well as related photovoltaic cells, articles, systems, and methods, are disclosed.

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims benefit under 35 U.S.C. §365(c) as acontinuation of co-pending international application PCT/US2011/049942having the international filing date of Aug. 31, 2011, which claimsbenefit under 35 U.S.C. §119 of U.S. Provisional Application Ser. No.61/379,563, filed Sep. 2, 2010, the contents of both of which are herebyincorporated by reference.

TECHNICAL FIELD

This disclosure relates to novel photoactive polymers, as well asrelated photovoltaic cells, articles, systems, and methods.

BACKGROUND

Photovoltaic cells are commonly used to transfer energy in the form oflight into energy in the form of electricity. A typical photovoltaiccell includes a photoactive material disposed between two electrodes.Generally, light passes through one or both of the electrodes tointeract with the photoactive material, thereby generating chargecarriers (i.e., electrons and holes). As a result, the ability of thephotoactive material to absorb light and general charge carriers canlimit the overall efficiency of a photovoltaic cell.

SUMMARY

This disclosure is based on the unexpected discovery that introducing afluoro substituted phenyl moiety into a photoactive polymer (e.g., aconjugated polymer) could result in a novel polymer having a loweredhighest occupied molecular orbital (HOMO) than a conventionalphotoactive polymer without significantly changing the bandgap of thephotoactive polymer (e.g., by lowering the HOMO and the lowestunoccupied molecular orbital (LUMO) simultaneously). As a result, thenovel polymer can be used to prepare a photovoltaic cell with animproved open circuit voltage (V_(oc)) and improved energy conversionefficiency.

In one aspect, this disclosure features a polymer that includes firstand second comonomer repeat units. The first comonomer repeat unitincludes a phenyl moiety substituted with 2-4 halo groups or 2-4 C₁-C₄trihaloalkyl groups. The second comonomer repeat unit includes abenzodithiophene moiety, a cyclopentadithiazole moiety, abenzothiadiazole moiety, a thiadiazoloquinoxaline moiety, abenzoisothiazole moiety, a benzothiazole moiety, a dibenzosilole moiety,a thienothiophene moiety, a carbazole moiety, a dithienothiophenemoiety, a tetrahydroisoindole moiety, a fluorene moiety, a silolemoiety, a cyclopentadithiophene moiety, a thiazole moiety, athiazolothiazole moiety, a naphthothiadiazole moiety, a thienopyrazinemoiety, a silacyclopentadithiophene moiety, an oxazole moiety, animidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, or a benzotriazole moiety.

In another aspect, this disclosure features a polymer of formula (I):

in which m is 0 or 1; each p, independently, is 0, 1, or 2; n is aninteger greater than 1; X is a phenyl moiety substituted with 2-4 halogroups or 2-4 C₁-C₄ trihaloalkyl groups; each D, independently, is abenzodithiophene moiety, a carbazole moiety, a fluorene moiety, acyclopentadithiophene moiety, or a silacyclopentadithiophene moiety; Ais a cyclopentadithiazole moiety, a benzothiadiazole moiety, athiadiazoloquinoxaline moiety, a benzoisothiazole moiety, abenzothiazole moiety, a thienothiophene moiety, a tetrahydroisoindolemoiety, a thiazole moiety, a thiazolothiazole moiety, anaphthothiadiazole moiety, a thienopyrazine moiety, an oxazole moiety,an imidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, a benzotriazole moiety, or afuran moiety; and each T, independently, is a thienothiophene moiety, athiazole moiety, a thiophene moiety, a selenophene moiety, a thiadiazolemoiety, or a furan moiety.

In still another aspect, this disclosure features an article thatincludes a first electrode, a second electrode, and a photoactivematerial disposed between the first and second electrodes. Thephotoactive material includes one or more of the polymers describedabove. The article is configured as a photovoltaic cell.

Features and advantages of the polymers and photovoltaic cells describedin this disclosure will be apparent from the description, drawings, andclaims.

DESCRIPTION OF DRAWINGS

FIG. 1 is a cross-sectional view of an embodiment of a photovoltaiccell.

FIG. 2 is a cross-sectional view of an embodiment of a tandemphotovoltaic cell.

FIG. 3 is a schematic of a system containing multiple photovoltaic cellselectrically connected in series.

FIG. 4 is a schematic of a system containing multiple photovoltaic cellselectrically connected in parallel.

Like reference symbols in the various drawings indicate like elements.

DETAILED DESCRIPTION

FIG. 1 shows a cross-sectional view of a photovoltaic cell 100 thatincludes a substrate 110, an electrode 120, an optional hole blockinglayer 130, a photoactive layer 140 (e.g., containing an electronacceptor material and an electron donor material), a hole carrier layer150, an electrode 160, and a substrate 170.

In general, during use, light can impinge on the surface of substrate110, and passes through substrate 110, electrode 120, and optional holeblocking layer 130. The light then interacts with photoactive layer 140,causing electrons to be transferred from the electron donor material(e.g., a photoactive polymer described herein) to the electron acceptormaterial (e.g., a substituted fullerene). The electron acceptor materialthen transmits the electrons through optional hole blocking layer 130 toelectrode 120, and the electron donor material transfers holes throughhole carrier layer 150 to electrode 160. Electrodes 120 and 160 are inelectrical connection via an external load so that electrons pass fromelectrode 120 through the load to electrode 160.

In some embodiments, the electron donor or acceptor material can includeone or more polymers (e.g., homopolymers or copolymers). A polymermentioned herein includes at least two identical or different monomerrepeat units (e.g., at least 5 monomer repeat units, at least 10 monomerrepeat units, at least 50 monomer repeat units, at least 100 monomerrepeat units, or at least 500 monomer repeat units). A homopolymermentioned herein refers to a polymer that includes monomer repeat unitswith the same chemical structure. A copolymer mentioned herein refers toa polymer that includes at is least two (e.g., three or four) monomerrepeat units with different chemical structures. In general, thepolymers suitable for use as electron donor or acceptor materials arephotoactive.

In general, the electron donor material suitable for photoactive layer140 can be a photoactive copolymer that includes a first comonomerrepeat unit and a second comonomer repeat unit different from the firstmonomer repeat unit. In such embodiments, the photoactive polymeroptionally further includes a third comonomer repeat unit different fromthe first and second comonomer repeat units or a fourth comonomer repeatunit different from the first, second, and third comonomer repeat unit.

In some embodiments, the electron donor material can include aphotoactive polymer (e.g., a conjugate polymer) that includes a firstcomonomer repeat unit containing a phenyl moiety substituted with two,three, or four halo (e.g., fluoro, chloro, or bromo) groups, or two,three, or four C₁-C₄ trihaloalkyl groups (e.g., trifluoromethyl).Without wishing to be bound by theory, it is believed that such aphotoactive polymer can possess a HOMO (e.g., between about −6.3 eV andabout −5.4 eV) lower than that of a conventional photoactive polymerwhile still maintaining a desirable bandgap (e.g., between about 1.4 eVand about 2.3 eV). As a result, such a photoactive polymer can be usedto prepare a photovoltaic cell with an improved V_(oc) and improvedenergy conversion efficiency. In addition, such a photoactive polymercan exhibit a lower LUMO, improved hole mobility, and improved fillfactor compared to a conventional photoactive polymer. Without wishingto be bound by theory, it is believed that such a photoactive polymercan be used to prepare a photoactive layer with a sufficiently largethickness (e.g., at least about 150 nm, at least about 200 nm, at leastabout 250 nm, or at least about 300 nm) while still maintaining asufficiently high fill factor. A photoactive layer with such a thicknesscan be readily prepared by using a continuous roll-to-roll process,thereby reducing the manufacturing costs of a photovoltaic cell.

In some embodiments, the first comonomer repeat unit in the photoactivepolymer can include a phenyl moiety of formula (1):

in which each of R₁, R₂, R₃, and R₄, independently, is H, halo (e.g.,fluoro, chloro, or bromo), or C₁-C₄ trihaloalkyl (e.g.,trifluoromethyl), provided that at least two of R₁, R₂, R₃, and R₄ ishalo or C₁-C₄ trihaloalkyl.

In some embodiments, the photoactive polymer can include a secondcomonomer repeat unit different from the first comonomer repeat unit.For example, the second comonomer repeat unit can include abenzodithiophene moiety, a cyclopentadithiazole moiety, abenzothiadiazole moiety, a thiadiazoloquinoxaline moiety, abenzoisothiazole moiety, a benzothiazole moiety, a dibenzosilole moiety,a thienothiophene moiety, a carbazole moiety, a dithienothiophenemoiety, a tetrahydroisoindole moiety, a fluorene moiety, a silolemoiety, a cyclopentadithiophene moiety, a thiazole moiety, athiazolothiazole moiety, a naphthothiadiazole moiety, a thienopyrazinemoiety, a silacyclopentadithiophene moiety, an oxazole moiety, animidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, or a benzotriazole moiety.

In some embodiments, the second comonomer repeat unit in the photoactivepolymer can include a benzodithiophene moiety of formula (2), abenzodithiophene moiety of formula (3), a cyclopentadithiazole moiety offormula (4), a benzothiadiazole moiety of formula (5), athiadiazoloquinoxaline moiety of formula (6), a benzoisothiazole moietyof formula (7), a benzothiazole moiety of formula (8), a dibenzosilolemoiety of formula (9), a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a carbazole moiety of formula(12), a dithienothiophene moiety of formula (13), a tetrahydroisoindolemoiety of formula (14), a fluorene moiety of formula (15), a silolemoiety of formula (16), a cyclopentadithiophene moiety of formula (17),a thiazole moiety of formula (18), a thiazolothiazole moiety of formula(19), a naphthothiadiazole is moiety of formula (20), a thienopyrazinemoiety of formula (21), a silacyclopentadithiophene moiety of formula(22), an oxazole moiety of formula (23), an imidazole moiety of formula(24), a pyrimidine moiety of formula (25), a benzoxazole moiety offormula (26), a benzimidazole moiety of formula (27), a pyridopyrazinemoiety of formula (28), a pyrazinopyridazine moiety of formula (29), apyrazinoquinoxaline moiety of formula (30), a thiadiazolopyridine moietyof formula (31), a thiadiazolopyridazine moiety of formula (32), abenzooxadiazole moiety of formula (33), an oxadiazolopyridine moiety offormula (34), an oxadiazolopyridazine moiety of formula (35), abenzoselenadiazole moiety of formula (36), a benzobisoxazole moiety offormula (37), a benzobisoxazole moiety of formula (38), athienothiadiazole moiety of formula (39), a thienopyrroledione moiety offormula (40), a tetrazine moiety of formula (41), a pyrrolopyrroledionemoiety of formula (42), a benzotriazole moiety of formula (47), or abenzodithiophene moiety of formula (48):

in each of X and Y, independently, is CH₂, O, or S; each of R₅, R₆, R₇,and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy, aryl,heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR, COR,COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl.For example, the second comonomer repeat unit can include thebenzodithiophene moiety of formula (2) or the silacyclopentadithiophenemoiety of formula (22), in which each of R₅, R₆, R₇, and R₈,independently, is H, C₁-C₂₄ alkyl (e.g., C₈H₁₇ alkyl), or COOR (e.g.,COOC₁₂H₂₅).

As used herein, an alkyl can be saturated or unsaturated and branched orstraight chained. A C₁-C₂₄ alkyl contains any of 1 to 24 carbon atoms.Examples of alkyl moieties include —CH₃, —CH₂—, —CH₂═CH₂—, —CH₂—CH═CH₂,and branched —C₃H₇. An alkoxy can be branched or straight chained andsaturated or unsaturated. A C₁-C₂₄ alkoxy contains an oxygen radical andany of 1 to 24 carbon atoms. Examples of alkoxy moieties include —OCH₃and —OCH═CH—CH₃. A cycloalkyl can be either saturated or unsaturated andcan contain one or more (e.g., two, three, four, or five) rings. AC₃-C₂₄ cycloalkyl contains any of 3 to 24 carbon atoms. Examples ofcycloalkyl moieties include cyclohexyl and cyclohexen-3-yl. Aheterocycloalkyl can also be either saturated or unsaturated and cancontain one or more (e.g., two, three, four, or five) rings. A C₃-C₂₄heterocycloalkyl contains at least one ring heteroatom (e.g., O, N, andS) and any of 3 to 24 carbon atoms. Examples of heterocycloalkylmoieties include 4-tetrahydropyranyl and 4-pyranyl. An aryl can containone or more (e.g., two, three, four, or five) aromatic rings. Examplesof aryl moieties include phenyl, phenylene, naphthyl, naphthylene,pyrenyl, anthryl, and phenanthryl. A heteroaryl can contain one or more(e.g., two, three, four, or five) aromatic rings, at least one of whichcontains at least one ring heteroatom (e.g., O, N, and S). Examples ofheteroaryl moieties include furyl, furylene, fluorenyl, pyrrolyl,thienyl, oxazolyl, imidazolyl, thiazolyl, pyridyl, pyrimidinyl,quinazolinyl, quinolyl, isoquinolyl, and indolyl.

Alkyl, alkoxy, cycloalkyl, heterocycloalkyl, aryl, and heteroarylmentioned herein include both substituted and unsubstituted moieties,unless specified otherwise. Examples of substituents on cycloalkyl,heterocycloalkyl, aryl, and heteroaryl include C₁-C₂₀ alkyl, C₃-C₂₀cycloalkyl, C₁-C₂₀ alkoxy, aryl, aryloxy, heteroaryl, heteroaryloxy,amino, C₁-C₁₀ alkylamino, C₁-C₂₀ dialkylamino, arylamino, diarylamino,hydroxyl, halogen, thio, C₁-C₁₀ alkylthio, arylthio, C₁-C₁₀alkylsulfonyl, arylsulfonyl, cyano, nitro, acyl, acyloxy, carboxyl, andcarboxylic ester. Examples of substituents on alkyl include all of theabove-recited substituents except C₁-C₂₀ alkyl. Cycloalkyl,heterocycloalkyl, aryl, and heteroaryl also include fused groups.

In some embodiments, the photoactive polymer can include an optionalthird comonomer repeat unit different from the first and secondcomonomer repeat units. For example, the optional third comonomer repeatunit can include a benzodithiophene moiety, a cyclopentadithiazolemoiety, a benzothiadiazole moiety, a thiadiazoloquinoxaline moiety, abenzoisothiazole moiety, a benzothiazole moiety, a dibenzosilole moiety,a thienothiophene moiety, a carbazole moiety, a dithienothiophenemoiety, a tetrahydroisoindole moiety, a fluorene moiety, a silolemoiety, a cyclopentadithiophene moiety, a thiazole moiety, athiazolothiazole moiety, a naphthothiadiazole moiety, a thienopyrazinemoiety, a silacyclopentadithiophene moiety, an oxazole moiety, animidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, or a benzotriazole moiety. Forexample, the optional third comonomer repeat unit can include any of themoieties of formulas (2)-(42), (47), and (48) described above. Asanother example, the optional third comonomer repeat unit can include athiophene moiety of formula (43), a selenophene moiety of formula (44),a thiadiazole moiety of formula (45), a quinoxaline moiety of formula(46), or a furan moiety of formula (49):

in which each of X and Y, independently, is CH₂, O, or S; and each ofR₅, R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl,CN, OR, COR, COOR, or CON(RR′), in which each of R and R′,independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl,or C₃-C₂₄ heterocycloalkyl. In some embodiments, the optional thirdcomonomer repeat unit in the electron donor material can include thebenzothiadiazole moiety of formula (5) or the thiazolothiazole moiety offormula (19), in which each of R₅ and R₆ is H.

In some embodiments, the photoactive polymer can include an optionalfourth comonomer repeat unit different from the first, second, and thirdcomonomer repeat units. For example, the optional fourth comonomerrepeat unit can include a thienothiophene moiety, a thiazole moiety, athiazolothiazole moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, or a furan moiety.

In some embodiments, the optional fourth comonomer repeat unit caninclude a thienothiophene moiety of formula (10), a thienothiophenemoiety of formula (11), a thiazole moiety of formula (18), a thiophenemoiety of formula (43), a selenophene moiety of formula (44), athiadiazole moiety of formula (45), or a furan moiety of formula (49):

in which each of R₅ and R₆ independently, is H, halo, C₁-C₂₄ alkyl,C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, CN, OR, COR, COOR, or CON(RR′), in which each of R andR′, independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄cycloalkyl, or C₃-C₂₄ heterocycloalkyl. For example, the optional fourthcomonomer repeat unit can include the thiophene moiety of formula (43),in which each of R₅ and R₆, independently, is H, halo (e.g., Cl), orC₁-C₂₄ alkyl (e.g., C₁₄H₂₉).

In general, the molar ratio of the first, second, and optional third andfourth monomer repeat units in a photoactive polymer suitable for use asan electron donor material can vary as desired. In some embodiments, themolar ratio of the second monomer repeat unit to the first or thirdmonomer repeat units is at least about 1:1 (e.g., at least about 2:1, atleast about 3:1, or at least about 4:1) and/or at most about 10:1 (e.g.,at most about 5:1, at most about 4:1, at most about 3:1, or at mostabout 2:1). In some embodiments, the molar ratio of the fourth monomerrepeat unit to the third monomer repeat units is at least about 1:1(e.g., at least about 2:1, at least about 3:1, or at least about 4:1)and/or at most about 10:1 (e.g., at most about 5:1, at most about 4:1,at most about 3:1, or at most about 2:1). For example, a copolymercontaining three monomer repeat units can have the first, second, andthird monomer repeat units in a molar ratio of about 1:2:1. As anotherexample, a copolymer containing four monomer repeat units can have thefirst, second, third, and fourth monomer repeat units in a molar ratioof about 1:2:1:2.

Exemplary photoactive polymers that can be used as an electron donormaterial in photoactive layer 140 include polymers 1-4 listed below:

Polymer 1 is an exemplary photoactive polymer containing first andsecond comonomer repeat units. Polymer 2 is an exemplary photoactivepolymer containing first, second, and third comonomer repeat units.Polymers 3 and 4 are exemplary photoactive polymers containing first,second, third, and fourth comonomer repeat units.

In some embodiments, the photoactive polymer can include a polymer offormula (I):

in which m is 0 or 1; each p, independently, is 0, 1, or 2; n is aninteger greater than 1; X is a phenyl moiety substituted with 2-4 halogroups or 2-4 C₁-C₄ trihaloalkyl groups; each D, independently, is abenzodithiophene moiety, a carbazole moiety, a fluorene moiety, acyclopentadithiophene moiety, or a silacyclopentadithiophene moiety; Ais a cyclopentadithiazole moiety, a benzothiadiazole moiety, athiadiazoloquinoxaline moiety, a benzoisothiazole moiety, abenzothiazole moiety, a thienothiophene moiety, a tetrahydroisoindolemoiety, a thiazole moiety, a thiazolothiazole moiety, anaphthothiadiazole moiety, a thienopyrazine moiety, an oxazole moiety,an imidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, a benzotriazole moiety, or afuran moiety; and each T, independently, is a thienothiophene moiety, athiazole moiety, a thiophene moiety, a selenophene moiety, a thiadiazolemoiety, or a furan moiety. In some embodiments, n is an integer rangingfrom at least 2 (e.g., at least 5, at least 10, at least 50, or at least100) to at most 1,000 (e.g., at most 750, at most 500, at 26 most 250,at most 100, or at most 75). Examples of polymers of formula (1) includepolymers 1-4 described above.

In some embodiments, X in formula (I) is the phenyl moiety of formula(1) described above. For example, each of R₁, R₂, R₃, and R₄ in formula(I), independently, can be halo (e.g., fluoro, chloro, or bromo).

In some embodiments, each D in formula (I), independently, is any one ofthe moieties of formulas (2), (3), (12), (15), (17), (22), and (48)described above. For example, each D, independently, can be thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H or C₁-C₂₄ alkyl. In someembodiments, each D is the silacyclopentadithiophene moiety of formula(22), in which each of R₅ and R₆ is C₈H₁₇ alkyl, and each of R₇ and R₈is H.

In some embodiments, A in formula (I) is any one of the moieties offormulas (4)-(8), (10), (11), (14), (18)-(21), (23)-(47), and (49)described above. For example, A can be the benzothiadiazole moiety offormula (5) or the thiazolothiazole moiety of formula (19), in whicheach of R₅ and R₆ is H.

In some embodiments, each T in formula (I), independently, is any one ofthe moieties of formulas (10), (11), (18), (43)-(45), and (49) describedabove. For example, when each p is 1, each T, independently, can be thethiophene moiety of formula (43), in which each of R₅ and R₆,independently, is H, halo (e.g., Cl), or C₁-C₂₄ alkyl (e.g., C₁₄H₂₉alkyl).

In some embodiments, the photoactive polymer described above can have aHOMO of at most about −5.4 eV (e.g., at most about −5.5 eV, at mostabout −5.6 eV, at most about −5.7 eV, or at most about −5.8 eV) and/orat least about −6.3 eV (e.g., at least about −6.2 eV, at least about−6.1 eV, at least about −6.0 eV, or at least about −5.9 eV).

In some embodiments, the photoactive polymer described above can have aLUMO of at most about −3.3 eV (e.g., at most about −3.4 eV, at mostabout −3.5 eV, at most about −3.6 eV, or at most about −3.7 eV) and/orat least about −4.2 eV (e.g., at least about −4.1 eV, at least about−4.0 eV, at least about −3.9 eV, or at least about −3.8 eV).

In some embodiments, the photoactive polymer described above can have a26 bandgap of at most about 2.3 eV (e.g., at most about 2.2 eV, at mostabout 2.1 eV, at most about 2.0 eV, or at most about 1.9 eV) and/or atleast about 1.4 eV (e.g., at least about 1.5 eV, at least about 1.6 eV,at least about 1.7 eV, or at least about 1.8 eV).

Without wishing to be bound by theory, it is believed that aphotovoltaic cell having one of the copolymers described above (e.g., apolymer containing the first, so second, and optional third and fourthmonomer repeat units described above) can have a high energy conversionefficiency. In some embodiments, such a photovoltaic cell can have anefficiency of at least about 4% (e.g., at least about 5%, at least about6%, or at least about 7%) under AM 1.5 conditions. Further, withoutwishing to be bound by theory, it is believed that other advantages ofthe copolymers described above include suitable band gap (e.g., 1.6-2.0eV) that can improve photocurrent and cell voltage, high positive chargemobility (e.g., 10⁻⁴ to 10⁻¹ cm²/Vs) that can facilitate chargeseparation in photoactive layer 140, and high solubility in an organicsolvent that can improve film forming ability and processability.

The photoactive polymers described above can be prepared by methodsknown in the art. For example, a copolymer can be prepared by across-coupling reaction between one or more monomers containing twoorganometallic groups (e.g., alkylstannyl groups, Grignard groups, oralkylzinc groups) and one or more monomers containing two halo groups(e.g., Cl, Br, or I) in the presence of a transition metal catalyst. Asanother example, a copolymer can be prepared by a cross-couplingreaction between one or more monomers containing two borate groups andone or more monomers containing two halo groups (e.g., Cl, Br, or I) inthe presence of a transition metal catalyst. Other methods that can beused to prepare the copolymers described above including Suzuki couplingreactions, Negishi coupling reactions, Kumada coupling reactions, andStille coupling reactions, all of which are well known in the art.Examples 1-4 below provide descriptions of how polymers 1-4 listed abovewere actually prepared.

The monomers suitable for preparing the photoactive polymers describedabove can be prepared by the methods described herein or by the methodsknow in the art, such as those described in U.S. patent application Ser.No. 11/486,536, Coppo et al., Macromolecules 2003, 36, 2705-2711, Kurtet al., J. Heterocycl. Chem. 1970, 6, 629, Chen et al., J. Am. Chem.Soc., (2006) 128(34), 10992-10993, Hou et al., Macromolecules (2004),37, 6299-6305, and Bijleveld et al., Adv. Funct. Mater., (2009), 19,3262-3270. The monomers can contain a non-aromatic double bond and oneor more asymmetric centers. Thus, they can occur as racemates andracemic mixtures, single enantiomers, individual diastereomers,diastereomeric mixtures, and cis- or trans-isomeric forms. All suchisomeric forms are contemplated.

In some embodiments, electron acceptor materials of photoactive layer140 can include fullerenes. In some embodiments, photoactive layer 140can include one or more unsubstituted fullerenes and/or one or moresubstituted fullerenes. Examples of unsubstituted fullerenes includeC₆₀, C₇₀, C₇₆, C₇₈, C₈₂, C₈₄, and C₉₂. Examples of substitutedfullerenes include fullerene substituted with phenyl-butyric acid methylesters (PCBMs, such as C61-phenyl-butyric acid methyl ester (C61-PCBM)and C71-phenyl-butyric acid methyl ester (C71-PCBM)) or fullerenessubstituted with C₁-C₂₀ alkoxy optionally further substituted withC₁-C₂₀ alkoxy and/or halo (e.g., (OCH₂CH₂)₂CH₃ or OCH₂CF₂OCF₂CF₂OCF₃).Without wishing to be bound by theory, it is believed that fullerenessubstituted with long-chain alkoxy groups (e.g., oligomeric ethyleneoxides) or fluorinated alkoxy groups have improved solubility in organicsolvents and can form a photoactive layer with improved morphology.Other examples of fullerenes have been described in, e.g.,commonly-owned co-pending U.S. Application Publication No. 2005-0279399.

Turning to other components of photovoltaic cell 100, substrate 110 isgenerally formed of a transparent material. As referred to herein, atransparent material is a material which, at the thickness used in aphotovoltaic cell 100, transmits at least about 60% (e.g., at leastabout 70%, at least about 75%, at least about 80%, at least about 85%)of incident light at a wavelength or a range of wavelengths used duringoperation of the photovoltaic cell. Exemplary materials from whichsubstrate 110 can be formed include polyethylene terephthalates,polyimides, polyethylene naphthalates, polymeric hydrocarbons,cellulosic polymers, polycarbonates, polyamides, polyethers, andpolyether ketones. In certain embodiments, the polymer can be afluorinated polymer. In some embodiments, combinations of polymericmaterials are used. In certain embodiments, different regions ofsubstrate 110 can be formed of different materials.

In general, substrate 110 can be flexible, semi-rigid or rigid (e.g.,glass). In some embodiments, substrate 110 has a flexural modulus ofless than about 5,000 megaPascals (e.g., less than about 1,000megaPascals or less than about 500 megaPascals). In certain embodiments,different regions of substrate 110 can be flexible, semi-rigid, orinflexible (e.g., one or more regions flexible and one or more differentregions semi-rigid, one or more regions flexible and one or moredifferent regions inflexible).

Typically, substrate 110 is at least about one micron (e.g., at leastabout five microns or at least about 10 microns) thick and/or at mostabout 1,000 microns (e.g., at most about 500 microns, at most about 300microns, at most about 200 microns, at most about 100 microns, or atmost about 50 microns) thick.

Generally, substrate 110 can be colored or non-colored. In someembodiments, one or more portions of substrate 110 is/are colored whileone or more different portions of substrate 110 is/are non-colored.

Substrate 110 can have one planar surface (e.g., the surface on whichlight impinges), two planar surfaces (e.g., the surface on which lightimpinges and the opposite surface), or no planar surfaces. A non-planarsurface of substrate 110 can, for example, be curved or stepped. In someembodiments, a non-planar surface of substrate 110 is patterned (e.g.,having patterned steps to form a Fresnel lens, a lenticular lens or a islenticular prism).

Electrode 120 is generally formed of an electrically conductivematerial. Exemplary electrically conductive materials includeelectrically conductive metals, electrically conductive alloys,electrically conductive polymers, and electrically conductive metaloxides. Exemplary electrically conductive metals include gold, silver,copper, aluminum, nickel, palladium, platinum, and titanium. Exemplaryelectrically conductive alloys include stainless steel (e.g., 332stainless steel, 316 stainless steel), alloys of gold, alloys of silver,alloys of copper, alloys of aluminum, alloys of nickel, alloys ofpalladium, alloys of platinum, and alloys of titanium. Exemplaryelectrically conducting polymers include polythiophenes (e.g., dopedpoly(3,4-ethylenedioxythiophene) (doped PEDOT)), polyanilines (e.g.,doped polyanilines), polypyrroles (e.g., doped polypyrroles). Exemplaryelectrically conducting metal oxides include indium tin oxide,fluorinated tin oxide, tin oxide and zinc oxide. In some embodiments,combinations of electrically conductive materials are used.

In some embodiments, electrode 120 can include a mesh electrode.Examples of mesh electrodes are described in co-pending U.S. PatentApplication Publication Nos. 20040187911 and 20060090791.

In some embodiments, a combination of the materials described above canbe used to form electrode 120.

Optionally, photovoltaic cell 100 can include a hole blocking layer 130.The hole blocking layer is generally formed of a material that, at thethickness used in photovoltaic cell 100, transports electrons toelectrode 120 and substantially blocks the transport of holes toelectrode 120. Examples of materials from which the hole blocking layercan be formed include LiF, metal oxides (e.g., zinc oxide, titaniumoxide), and amines (e.g., primary, secondary, or tertiary amines).Examples of amines suitable for use in a hole blocking layer have beendescribed, for example, in co-pending U.S. Application Publication No.2008-0264488.

Without wishing to be bound by theory, it is believed that whenphotovoltaic cell 100 includes a hole blocking layer made of amines, thehole blocking layer can facilitate the formation of ohmic contactbetween photoactive layer 140 and electrode 120 without being exposed toUV light, thereby reducing damage to photovoltaic cell 100 resulted fromUV exposure.

Typically, hole blocking layer 130 is at least about 0.02 micron (e.g.,at least about 0.03 micron, at least about 0.04 micron, or at leastabout 0.05 micron) thick and/or at most about 0.5 micron (e.g., at mostabout 0.4 micron, at most about 0.3 micron, at most about 0.2 micron, orat most about 0.1 micron) thick.

Hole carrier layer 150 is generally formed of a material that, at thethickness used in photovoltaic cell 100, transports holes to electrode160 and substantially blocks the transport of electrons to electrode160. Examples of materials from which layer 150 can be formed includepolythiophenes (e.g., PEDOT), polyanilines, polycarbazoles,polyvinylcarbazoles, polyphenylenes, polyphenylvinylenes, polysilanes,polythienylenevinylenes, polyisothianaphthanenes, and copolymersthereof. In some embodiments, hole carrier layer 150 can include adopant used in combination with one of the just-mentioned material.Examples of dopants include poly(styrene-sulfonate)s, polymeric sulfonicacids, or fluorinated polymers (e.g., fluorinated ion exchangepolymers).

In some embodiments, the materials that can be used to form hole carrierlayer 150 include metal oxides, such as titanium oxides, zinc oxides,tungsten oxides, molybdenum oxides, copper oxides, strontium copperoxides, or strontium titanium oxides. The metal oxides can be eitherundoped or doped with a dopant. Examples of dopants for metal oxidesinclude salts or acids of fluoride, chloride, bromide, and iodide.

In some embodiments, the materials that can be used to form hole carrierlayer 150 include carbon allotropes (e.g., carbon nanotubes). The carbonallotropes can be embedded in a polymer binder.

In some embodiments, the hole carrier materials can be in the form ofnanoparticles. The nanoparticles can have any suitable shape, such as aspherical, cylindrical, or rod-like shape.

In some embodiments, hole carrier layer 150 can include combinations ofhole carrier materials described above.

In general, the thickness of hole carrier layer 150 (i.e., the distancebetween the surface of hole carrier layer 150 in contact withphotoactive layer 140 and the surface of electrode 160 in contact withhole carrier layer 150) can be varied as desired. Typically, thethickness of hole carrier layer 150 is at least about 0.01 micron (e.g.,at least about 0.05 micron, at least about 0.1 micron, at least about0.2 micron, at least about 0.3 micron, or at least about 0.5 micron)and/or at most about five microns (e.g., at most about three microns, atmost about two microns, or at most about one micron). In someembodiments, the thickness of hole carrier layer 150 is from about 0.01micron to about 0.5 micron.

Electrode 160 is generally formed of an electrically conductivematerial, such as one or more of the electrically conductive materialsdescribed above with respect to electrode 120. In some embodiments,electrode 160 is formed of a combination of electrically conductivematerials. In certain embodiments, electrode 160 can be formed of a meshelectrode.

Substrate 170 can be identical to or different from substrate 110. Insome embodiments, substrate 170 can be formed of one or more suitablepolymers, such as the polymers used in substrate 110 described above.

In some embodiments, the photoactive polymers described above can beused as an electron donor material in a system in which two photovoltaiccells share a common electrode. Such a system is also known as tandemphotovoltaic cell. FIG. 2 shows a tandem photovoltaic cell 200 havingtwo semi-cells 202 and 204. Semi-cell 202 includes an electrode 220, anoptional hole blocking layer 230, a first photoactive layer 240, and arecombination layer 242. Semi-cell 204 includes recombination layer 242,a second photoactive layer 244, a hole carrier layer 250, and anelectrode 260. An external load is connected to photovoltaic cell 200via electrodes 220 and 260.

Depending on the production process and the desired device architecture,the current flow in a semi-cell can be reversed by changing theelectron/hole conductivity of a certain layer (e.g., changing holeblocking layer 230 to a hole carrier layer). By doing is so, thesemi-cells in a tandem cell can be electrically interconnected either inseries or in parallel.

A recombination layer refers to a layer in a tandem cell where theelectrons generated from a first semi-cell recombine with the holesgenerated from a second semi-cell. Recombination layer 242 typicallyincludes a p-type semiconductor material and an n-type semiconductormaterial. In general, n-type semiconductor materials selectivelytransport electrons and p-type semiconductor materials selectivelytransport holes. As a result, electrons generated from the firstsemi-cell recombine with holes generated from the second semi-cell atthe interface of the n-type and p-type semiconductor materials.

In some embodiments, the p-type semiconductor material includes apolymer and/or a metal oxide. Examples of p-type semiconductor polymersinclude the benzodithiophene-containing polymers described above,polythiophenes (e.g., poly(3,4-ethylene dioxythiophene) (PEDOT)),polyanilines, polyvinylcarbazoles, polyphenylenes, polyphenylvinylenes,polysilanes, polythienylenevinylenes, polyisothianaphthanenes,polycyclopentadithiophenes, polysilacyclopentadithiophenes,polycyclopentadithiazoles, polythiazoles, polybenzothiadiazoles,poly(thiophene oxide)s, poly(cyclopentadithiophene oxide)s,polythiadiazoloquinoxaline, polybenzoisothiazole, polybenzothiazole,polythienothiophene, poly(thienothiophene oxide), polydithienothiophene,poly(dithienothiophene oxide)s, polytetrahydroisoindoles, and copolymersthereof. The metal oxide can be an intrinsic p-type semiconductor (e.g.,copper oxides, strontium copper oxides, or strontium titanium oxides) ora metal oxide that forms a p-type semiconductor after doping with adopant (e.g., p-doped zinc oxides or p-doped titanium oxides). Examplesof dopants include salts or acids of fluoride, chloride, bromide, andiodide. In some embodiments, the metal oxide can be used in the form ofnanoparticles.

In some embodiments, the n-type semiconductor material (either anintrinsic or doped n-type semiconductor material) includes a metaloxide, such as titanium oxides, zinc oxides, tungsten oxides, molybdenumoxides, and combinations thereof. The metal oxide can be used in theform of nanoparticles. In other embodiments, the n-type semiconductormaterial includes a material selected from the group consisting offullerenes (such as those described above), inorganic nanoparticles,oxadiazoles, discotic liquid crystals, carbon nanorods, inorganicnanorods, polymers containing CN groups, polymers containing CF₃ groups,and combinations thereof.

In some embodiments, the p-type and n-type semiconductor materials areblended into one layer. In certain embodiments, recombination layer 242includes two layers, one layer including the p-type semiconductormaterial and the other layer including the n-type semiconductormaterial. In such embodiments, recombination layer 242 can furtherinclude an electrically conductive layer (e.g., a metal layer or mixedn-type and p-type semiconductor materials) at the interface of the twolayers.

In some embodiments, recombination layer 242 includes at least about 30wt % (e.g., at least about 40 wt % or at least about 50 wt %) and/or atmost about 70 wt % (e.g., at most about 60 wt % or at most about 50 wt%) of the p-type semiconductor material. In some embodiments,recombination layer 242 includes at least about 30 wt % (e.g., at leastabout 40 wt % or at least about 50 wt %) and/or at most about 70 wt %(e.g., at most about 60 wt % or at most about 50 wt %) of the n-typesemiconductor material.

Recombination layer 242 generally has a sufficient thickness so that thelayers underneath are protected from any solvent applied ontorecombination layer 242. In some embodiments, recombination layer 242can have a thickness of at least about 10 nm (e.g., at least about 20nm, at least about 50 nm, or at least about 100 nm) and/or at most about500 nm (e.g., at most about 200 nm, at most about 150 nm, or at mostabout 100 nm).

In general, recombination layer 242 is substantially transparent. Forexample, at the thickness used in a tandem photovoltaic cell 200,recombination layer 242 can transmit at least about 70% (e.g., at leastabout 75%, at least about 80%, at least about 85%, or at least about90%) of incident light at a wavelength or a range of wavelengths (e.g.,from about 350 nm to about 1,000 nm) used during operation of thephotovoltaic cell.

Recombination layer 242 generally has a sufficiently low surfaceresistance. In some embodiments, recombination layer 242 has a surfaceresistance of at most about 1×10⁶ ohm/square (e.g., at most about 5×10⁵ohm/square, at most about 2×10⁵ ohm/square, or at most about 1×10⁵ohm/square).

Without wishing to be bound by theory, it is believed that recombinationlayer 242 can be considered as a common electrode between two semi-cells(e.g., one including electrode 220, hole blocking layer 230, photoactivelayer 240, and recombination layer 242, and the other includerecombination layer 242, photoactive layer 244, hole carrier layer 250,and electrode 260) in photovoltaic cells 200. In some embodiments,recombination layer 242 can include an electrically conductive grid(e.g., mesh) material, such as those described above. An electricallyconductive grid material can provide a selective contact of the samepolarity (either p-type or n-type) to the semi-cells and provide ahighly conductive but transparent layer to transport electrons to aload.

In some embodiments, a one-layer recombination layer 242 can be preparedby applying a blend of an n-type semiconductor material and a p-typesemiconductor material on a photoactive layer. For example, an n-typesemiconductor and a p-type semiconductor can be first dispersed and/ordissolved in a solvent together to form a dispersion or solution, whichcan then be coated on a photoactive layer to form a recombination layer.

In some embodiments, a two-layer recombination layer can be prepared byapplying a layer of an n-type semiconductor material and a layer of ap-type semiconductor material separately. For example, when titaniumoxide nanoparticles are used as an n-type semiconductor material, alayer of titanium oxide nanoparticles can be formed by (1) dispersing aprecursor (e.g., a titanium salt) in a solvent (e.g., an anhydrousalcohol) to form a dispersion, (2) coating the dispersion on aphotoactive layer, (3) hydrolyzing the dispersion to form a titaniumoxide layer, and (4) drying the titanium oxide layer. As anotherexample, when a polymer (e.g., PEDOT) is used as a p-type semiconductor,a polymer layer can be formed by first dissolving the polymer in asolvent (e.g., an anhydrous alcohol) to form a solution and then coatingthe solution on a photoactive layer.

Other components in tandem cell 200 can be formed of the same materials,or have the same characteristics, as those in photovoltaic cell 100described above.

Other examples of tandem photovoltaic cells have been described in,e.g., commonly-owned co-pending U.S. Application Publication Nos.2007-0181179 and 2007-0246094.

In some embodiments, the semi-cells in a tandem cell are electricallyinterconnected in series. When connected in series, in general, thelayers can be in the order shown in FIG. 2. In certain embodiments, thesemi-cells in a tandem cell are electrically interconnected in parallel.When interconnected in parallel, a tandem cell having two semi-cells caninclude the following layers: a first electrode, a first hole blockinglayer, a first photoactive layer, a first hole carrier layer (which canserve as an electrode), a second hole carrier layer (which can serve asan electrode), a second photoactive layer, a second hole blocking layer,and a second electrode. In such embodiments, the first and second holecarrier layers can be either two separate layers or can be one singlelayer. In case the conductivity of the first and second hole carrierlayers is not sufficient, an additional layer (e.g., an electricallyconductive mesh layer such as a metal mesh layer) providing the requiredconductivity may be inserted between the first and second hole carrierlayers.

In some embodiments, a tandem cell can include more than two semi-cells(e.g., three, four, five, six, seven, eight, nine, ten, or moresemi-cells). In certain embodiments, some semi-cells can be electricallyinterconnected in series and some semi-cells can be electricallyinterconnected in parallel.

In general, the methods of preparing each layer in photovoltaic cellsdescribed in FIGS. 1 and 2 can vary as desired. In some embodiments, alayer can be prepared by a liquid-based coating process. In certainembodiments, a layer can be prepared via a gas phase-based coatingprocess, such as chemical or physical vapor deposition processes.

The term “liquid-based coating process” mentioned herein refers to aprocess that uses a liquid-based coating composition. Examples of theliquid-based coating composition include solutions, dispersions, orsuspensions. The liquid-based coating process can be carried out byusing at least one of the following processes: solution is coating, inkjet printing, spin coating, dip coating, knife coating, bar coating,spray coating, roller coating, slot coating, gravure coating,flexographic printing, or screen printing. Examples of liquid-basedcoating processes have been described in, for example, commonly-ownedco-pending U.S. Application Publication No. 2008-0006324.

In some embodiments, when a layer includes inorganic semiconductornanoparticles, the liquid-based coating process can be carried out by(1) mixing the nanoparticles with a solvent (e.g., an aqueous solvent oran anhydrous alcohol) to form a dispersion, (2) coating the dispersiononto a substrate, and (3) drying the coated dispersion. In certainembodiments, a liquid-based coating process for preparing a layercontaining inorganic metal oxide nanoparticles can be carried out by (1)dispersing a precursor (e.g., a titanium salt) in a suitable solvent(e.g., an anhydrous alcohol) to form a dispersion, (2) coating thedispersion on a substrate, (3) hydrolyzing the dispersion to form aninorganic semiconductor nanoparticles layer (e.g., a titanium oxidenanoparticles layer), and (4) drying the inorganic semiconductormaterial layer. In certain embodiments, the liquid-based coating processcan be carried out by a sol-gel process (e.g., by forming metal oxidenanoparticles as a sol-gel in a dispersion before coating the dispersionon a substrate).

In general, the liquid-based coating process used to prepare a layercontaining an organic semiconductor material can be the same as ordifferent from that used to prepare a layer containing an inorganicsemiconductor material. In some embodiments, to prepare a layerincluding an organic semiconductor material, the liquid-based coatingprocess can be carried out by mixing the organic semiconductor materialwith a solvent (e.g., an organic solvent) to form a solution or adispersion, coating the solution or dispersion on a substrate, anddrying the coated solution or dispersion.

In some embodiments, the photovoltaic cells described in FIGS. 1 and 2can be prepared in a continuous manufacturing process, such as aroll-to-roll process, thereby significantly reducing the manufacturingcost. Examples of roll-to-roll processes have been described in, forexample, commonly-owned co-pending U.S. Application Publication No.2005-0263179.

While certain embodiments have been disclosed, other embodiments arealso possible.

In some embodiments, photovoltaic cell 100 includes a cathode as abottom electrode and an anode as a top electrode. In some embodiments,photovoltaic cell 100 can include an anode as a bottom electrode and acathode as a top electrode.

In some embodiments, photovoltaic cell 100 can include the layers shownin FIG. 1 in a reverse order. In other words, photovoltaic cell 100 caninclude these layers from the bottom to the top in the followingsequence: a substrate 170, an electrode 160, a hole carrier layer 150, aphotoactive layer 140, an optional hole blocking layer 130, an electrode120, and a substrate 110.

In some embodiments, one of substrates 110 and 170 can be transparent.In other embodiments, both of substrates 110 and 170 can be transparent.

In some embodiments, multiple photovoltaic cells can be electricallyconnected to form a photovoltaic system. As an example, FIG. 3 is aschematic of a photovoltaic system 300 having a module 310 containing aplurality of photovoltaic cells 320. Cells 320 are electricallyconnected in series, and system 300 is electrically connected to a load330. As another example, FIG. 4 is a schematic of a photovoltaic system400 having a module 410 that contains a plurality of photovoltaic cells420. Cells 420 are electrically connected in parallel, and system 400 iselectrically connected to a load 430. In some embodiments, some (e.g.,all) of the photovoltaic cells in a photovoltaic system can be disposedon one or more common substrates. In certain embodiments, somephotovoltaic cells in a photovoltaic system are electrically connectedin series, and some of the photovoltaic cells in the photovoltaic systemare electrically connected in parallel.

While organic photovoltaic cells have been described, other photovoltaiccells can also be integrated with one of the polymers described herein.Examples of such photovoltaic cells include dye sensitized photovoltaiccells and inorganic photoactive cells with a photoactive material formedof amorphous silicon, cadmium selenide, cadmium telluride, copper indiumselenide, and copper indium gallium selenide. In some embodiments, ahybrid photovoltaic cell can be integrated with one of the polymersdescribed herein.

While photovoltaic cells have been described above, in some embodiments,the polymers described herein can be used in other devices and systems.For example, the polymers can be used in suitable organic semiconductivedevices, such as field effect transistors, photodetectors (e.g., IRdetectors), photovoltaic detectors, imaging devices (e.g., ROB imagingdevices for cameras or medical imaging systems), light emitting diodes(LEDs) (e.g., organic LEDs (OLEDs) or IR or near IR LEDs), lasingdevices, conversion layers (e.g., layers that convert visible emissioninto IR emission), amplifiers and emitters for telecommunication (e.g.,dopants for fibers), storage elements (e.g., holographic storageelements), and electrochromic devices (e.g., electrochromic displays).

The contents of all publications cited herein (e.g., patents, patentapplication publications, and articles) are hereby incorporated byreference in their entirety.

The following examples are illustrative and not intended to be limiting.

Example 1 Synthesis of2,6-dibromo-didodecyl-4,8-benzodithiophenedicarboxylate

2,6-Dibromo-didodecyl-4,8-benzodithiophenedicarboxylate was synthesizedbased on the Scheme below.

In a one-necked flask, 3-thienylmalonic acid (10.0 g, 53.7 mmol) and1-dodecanol (4 eq., 40.0 g, 215 mmol) were dissolved in THF (80 mL) atroom temperature. To this solution was added methanesulphonic acid (1.99g, 20.7 mmol). The reaction mixture was stirred at room temperature for3 days. The solvent was then evaporated at 40° C. The residue waspurified by column chromatography (eluent: CH₂Cl₂) to give compound 1(yield: 18.0 g, 69%). ¹H NMR (CDCl₃): 0.9 (6H, t), 1.3 (36H, m), 1.7(4H, m), 4.2 (4H, t), 4.8 (1H, s), 7.2 (1H, d), 7.3 (1H, d), 7.4 (1H,s).

In a two-necked flask under argon, a solution of Fe(ClO₄)₃ in methanol(320 mL) was prepared at 0° C. and a dispersion of compound 1 inmethanol (120 mL) was added to the solution. After the resultantsolution was stirred at 60° C. for 4 hours under argon, the solvent wasevaporated under vacuum at room temperature. After water (100 mL) wasthen added to the residue thus formed, the aqueous layer was extractedwith CH₂Cl₂ (100 mL×2) and the organic layer was dried and concentrated.The crude product thus obtained was purified by flash chromatography(eluent: CH₂Cl₂:hexane=3:2) to give compound 2 (yield: 9.0 g, 50.2%). ¹HNMR (CDCl₃); 0.9 (12H, t), 1.3 (72H, m), 1.7 (8H, m), 4.2 (8H, t), 7.3(2H, d), 7.4 (2H, d).

In a one-necked flask, compound 2 (9.0 g, 8.65 mmol) was dispersed inDMF (80 mL). The resultant mixture was stirred at 120° C. for 10 minutesuntil the solution became clear. After air was purged in the flask, NaI(800 mg) was added and the reaction mixture was refluxed for 24 hours.After the solvent was evaporated under vacuum, water (30 mL) was addedto the residue to form a mixture, which was extracted with CH₂Cl₂. Theorganic layers from the extraction were combined, dried, andconcentrated. The crude product was purified by flash chromatography(eluent: CH₂Cl₂:hexane=7:3) to give compound 3 (yield: 1.75 g, 32.9%).¹H NMR (CDCl₃): 0.9 (6H, t), 1.3 (28H, m), 1.4 (4H, m), 1.6 (4H, m), 1.9(4H, m), 4.6 (4H, t), 7.8 (2H, d), 8.3 (2H, d).

In a two-necked flask, compound 3 (1.75 g, 2.85 mmol) was dissolved inCH₂Cl₂ (100 mL). A solution of Br₂ (3 eq., 1.37 g, 8.55 mmol) dissolvedin 10 mL CH₂Cl₂ was added to the above solution dropwise. After theaddition was complete, the reaction mixture was stirred at roomtemperature overnight. A saturated sodium bisulfite solution was thenadded to the reaction mixture. After the mixture was extracted withCH₂Cl₂, the organic layers were combined, dried, and concentrated. Thecrude product was purified by flash chromatography(eluent:hexane:CH₂Cl₂=3:2) to give compound 4, i.e.,2,6-dibromo-didodecyl-4,8-benzodithiophenedicarboxylate (yield: 0.93 g,42.3%). ¹H NMR (CDCl³): 0.9 (6H, t), 1.3 (28H, m), 1.4 (4H, m), 1.6 (4H,m) 1.9 (4H, m), 4.6 (4H, t), 8.3 (2H, s).

Example 2 Synthesis of Polymer 1

2,6-Dibromo-didodecyl-4,8-benzodithiophenedicarboxylate obtained Example1 (1.6 g; 2.07 mmol) was placed in a two-necked flask and treated withevacuation-argon cycle three times. 300 mL freshly distilled THF wasadded to the above flask via a cannula and cooled down to −78° C. A 2.85M solution of n-butyl-lithium in hexane (2.18 mL, 3 eq.; 6.22 mmol) wasadded dropwise to the above solution at −78° C. After the solution wasthen stirred at −78° C. for one hour, a 1.0 M trimethyltin chloride inhexane (7.25 mL, 7.25 mmol) was added in one portion. The reactionmixture was warmed to room temperature and was stirred at roomtemperature for two hours. The mixture was then quenched by addition ofwater (200 mL). After the mixture was extracted with diethyl ether threetimes, the organic layers were combined, washed with a brine solution,dried over anhydrous magnesium sulfate, concentrated at room temperatureunder high vacuum. The crude bistin product was purified by a short pathcolumn chromatography (eluent: 40% dichloromethane in hexane) to give apure product as a pale yellow solid (1.2 g; 65% yield).

The bistin compound obtained above (150 mg; 0.17 mmol) was placed in aflask covered by an aluminum foil to protect it from a light. Afteranhydrous toluene (60 mL) is was added to the flask via a syringe, thesolution was bubbled with argon for 10 minutes. In a two-necked flask,3,6-dibromo-1,2,4,5-tetrafluorobenzene (48.3 mg, 0.92 eq.; 0.16 mmol),Pd₂dba₃ (2.5%, 4.26×10⁻⁶ mol, 3.9 mg), and tri-o-tolyphosphine (20%,3.41×10⁻⁵ mol, 10.4 mg) were added and treated with evacuation-argoncycle three times. The bistin compound dissolved in toluene was added tothis flask via a syringe and the flask was again treated withevacuation-argon cycle three times. The reaction mixture was thenrefluxed for 3 days. After cooling to 60° C., an aqueous solution ofsodium diethylthiocarbamate trihydrate (4.2 g in 90 mL water) was addedto the reaction mixture and the mixture was stirred at 80° C. overnight.After the resultant solution was washed with water three times, theorganic layer was poured into 300 mL methanol to form a precipitate. Theprecipitate was subjected to sequential Soxhlet extractions withmethanol, acetone, hexane, dichloromethane, chloroform, andchlorobenzene. The chloroform and chlorobenzene fractions wereprecipitated again by pouring into methanol. The resultant solids weredried in vacuum to give 150 mg polymer 1. M_(n) for the major fractionwas about 6,000.

Example 3 Synthesis of1,4-Bis(2-bromo-4,4′-bis(2-ethylhexyl)dithieno[3,2-b:2′,3′-d]silole)-2,3,5,6-tetrafluorobenzene

4,4′-bis(2-ethylhexyl)dithieno[3,2-b:2′,3′-d]silole (1.68 g, 4.0 mmol)was dissolved in 50 mL of dry THF. After the solution was cooled to −78°C., BuLi (1.40 mL, 4.0 mmol) was added into the solution. After reactionmixture was stirred at −78° C. for 30 minutes, SnMe₃Cl (4.0 mL, 4.0mmol) was added into the reaction flask by syringe. The reaction mixturewas then allowed to be warmed to room temperature.1,4-Dibromo-2,3,5,6-tetrafluorobenzene (0.61 g, 2.0 mmol) andbis(triphenylphosphine)palladium(II) chloride (0.14 g, 0.20 mmol) weredissolved in 5 mL of THF. The resultant solution was then added into theabove solution by syringe. The reaction mixture was refluxed thenovernight. After the reaction was cooled down, it was quenched by water,and extracted by dichloromethane. The crude product was concentrated byrotary evaporation, and purified by column chromatography to give1,4-bis(2-bromo-4,4′-bis(2-ethylhexyl)dithieno[3,2-b:2′,3′-d]silole)-2,3,5,6-tetrafluorobenzeneas yellow oil (1.4 g, 72%).

1,4-Bis(2-bromo-4,4′-bis(2-ethylhexyl)dithieno[3,2-b:2′,3′-d]silole)-2,3,5,6-tetrafluorobenzene(0.98 g, 1.0 mmol) obtained above and NBS (0.36 g, 2.0 mmol) weredissolved in 30 mL of chloroform. The solution was refluxed for 1 hour.After the reaction mixture was cooled to room temperature, water wasadded to quench the reaction. The organic layer was extracted bychloroform to afford a crude product. The crude product was purified bycolumn chromatography to give1,4-bis(2-bromo-4,4′-bis(2-ethylhexyl)dithieno[3,2-b:2′,3′-d]silole)-2,3,5,6-tetrafluorobenzeneas a yellow solid (1.08 g, 95%).

Example 4 Synthesis of2,5-bis(5-trimethylstannyl-3-tetradecyl-2-thienyl)-thiazolo[5,4-d]thiazole

To a 100 mL Schlenk flask was placed 250 mg (0.29 mmol) of2,5-bis(5-bromo-3-tetradecyl-2-thienyl)-thiazolo[5,4-d]thiazole. Theflask was evacuated and refilled with Ar three times. 35 mL of dry THFwas added to the flask. The flask was subsequently cooled to −78° C.n-Butyl lithium (0.64 mmol) was then added dropwise to the abovesolution. After the solution was stirred at −78° C. for 1 hour, 0.7 mLof 1.0 M solution of trimethyl tin chloride was syringed into thereaction mixture. After the solution was allowed to warm up to roomtemperature, 100 mL of diethyl ether was added to the solution. Thesolution was washed three times with 100 mL of water and then theorganic layer was dried over anhydrous MgSO₄. After the solvent wasremoved in vacuum,2,5-bis(5-trimethylstannyl-3-tetradecyl-2-thienyl)-thiazolo[5,4-d]thiazolewas isolated in quantitative yield.

Example 5 Synthesis of Polymer 3

The2,5-bis(5-trimethylstannyl-3-tetradecyl-2-thienyl)-thiazolo[5,4-d]thiazolewas transferred to a 100 mL three neck round bottom flask. The followingreagents were then added to the three neck flask: 7 mg (7 μmol) ofPd₂(dba)₃, 18 mg (59 μmol) of tri-o-tolyl-phosphine, 332 mg (0.29 mmol)of1,4-bis(2-bromo-4,4′-bis(2-ethylhexyl)dithieno[3,2-b:2′,3′-d]silole)-2,3,5,6-tetrafluorobenzene,and 20 mL of dry toluene. This reaction mixture was refluxed for twodays and then cooled to 80° C. An aqueous solution of sodiumdiethyldithiocarbamate trihydrate (1.5 g in 20 mL water) was syringedinto the flask and the mixture was stirred together at 80° C. for 12hours. After the mixture was cooled to room temperature, the organicphase was separated from the aqueous layer. The organic layer was pouredinto methanol (200 mL) to form a polymer precipitate. The polymerprecipitate was then collected and purified by soxhlet extraction. Thefinal extraction yielded 123 mg (M_(n)=31 kDa) ofpoly[1,4-bis(4,4′-bis(2-ethylhexyl)dithieno-[3,2-b:2′,3′-d]silole)-2,3,5,6-tetrafluorobenzene-alt-2,5-bis(3-tetradecyl-2-thienyl)-thiazolo[5,4-d]thiazole].

Example 6 Synthesis of Polymer 2

Polymer 2 (M_(n)=41 kDa) was prepared in a manner similar to thatdescribed in Example 3 using corresponding monomers.

Example 7 Synthesis of Polymer 4

Polymer 4 (M_(n)=22 kDa) was prepared in a manner similar to thatdescribed in Example 3 using corresponding monomers.

Example 8 Measurements of Physical Properties of Polymers 1-4

The HOMO/LUMO values of Polymers 1-4 were measured by cyclicvoltammetry. Cyclic voltammetry measurements were performed by dropcasting the polymer from an o-dichlorobenzene solution (1 mg/mL) onto a3.0 mm diameter glassy carbon electrode. The counter electrode was aplatinum wire. The reference electrode was Ag/AgNO₃ (0.01M) in 0.1MnBu₄NPF₆/CH3CN which contacted the electrolyte solution using a porousvycor salt bridge filled with electrolyte. The electrolyte solution was0.1M nBu₄NPF₆ in acetonitrile. The acetonitrile was Chromasolve gradefrom Sigma-Aldrich used as received. All electrochemistry was done underhigh purity argon atmosphere using a BAS100B/W electrochemical analyzer.The scan rate was 20 mV/s with the scan initiated in the oxidativedirection. Ferrocene, purified by sublimation, was used as an externalreference to convert potentials to the SCE scale. The vacuum level ofSCE is assumed to be −4.7 eV. The results were summarized in Table 1below.

TABLE 1 Photoactive HOMO LUMO E_(g)(ec)^(a) E_(g)(opt, soln)^(b)E_(g)(opt, film)^(c) Polymer (eV) (eV) (eV) (eV) (eV) Polymer 1 −6.1−4.05 2.05 2.10 — Polymer 2 −5.42 −3.72 1.7 1.70 1.69 Polymer 3 −5.52−3.67 1.85 1.89 1.85 Polymer 4 −5.7 −3.82 1.88 1.91 — ^(a.)Bandgapobtained from the cyclic voltammetry measurements described above.^(b.)Bandgap obtained from UV-Vis measurements of photoactive polymersolutions. ^(c.)Bandgap obtained from UV-Vis measurements of photoactivepolymer films.

UV-Visible spectra of Polymers 1-4 were acquired on a Perkin-ElmerLambda35 spectro-photometer. Stock samples of the polymers ino-dichlorobenzene (o-DCB) at a 1 mg/mL concentration were diluted witho-DCB to prepare solutions that gave maximum peak intensity between 0.70and 0.95 absorbance units. The path length of the quartz cuvettes was 1cm. The instrument was used in double beam mode with a reference 1 cmquartz cuvette containing o-DCB. HPLC grade (Chromosolv brand fromSigma-Aldrich) o-DCB was used. Spectra were taken at ambienttemperature. The results are summarized in Table 2 below.

TABLE 2 Photoactive E_(g)(opt, soln) Polymer λ_(max) (nm) (eV) Polymer 1486 2.10 Polymer 2 615,660 1.70 Polymer 3 570,616 1.89 Polymer 4 570,6151.91

Example 9 Fabrication of Photovoltaic Cells Using Photoactive Polymers2-4

Photoactive polymers 2-4 were used to fabricate inverted organicphotovoltaic to cells containing a glass substrate with a transparentpre-patterned indium tin oxide (ITO) bottom electrode, a hole blockinglayer on top of the ITO electrode, a photoactive layer on top of thehole blocking layer, a hole carrier layer on top of the photoactivelayer, and a top silver electrode. The hole blocking layer contained acrosslinked polyamine and the hole carrier layer contained a thiophenepolymer in the HIL family available from Air Products and Chemicals,Inc. The photoactive layer was formed from a blend of a photoactivepolymer and PCBM (1:2 by weight) dissolved in 1,2-dichlorobenzene at aconcentration of 0.6% by weight by using a blade-coating technique. Thephotoactive polymer solution was stirred at 80° C. for at least 12 hoursbefore coating. During the blade-coating process, the solution was keptunder stirring at 80° C. while the blade-coater temperature wasmaintained at 50° C. The thickness of the photoactive layer was adjustedby the blade speed and the volume of solution deposited.

The current density-voltage characteristics of the devices were measuredas described in Waldauf et al., App. Phys. Lett., 89, 233517 (2006). Theresults are summarized in Table 3 below.

TABLE 3 Photovoltaic Conversion Fill Factor Open-Circuit Short-CircuitCell Efficiency (%) (%) Voltage (mV) Current (mA/cm²) Cell having 4.4652 690 12.43 polymer 2 Cell having 4.56 63 740 9.77 polymer 3 Cellhaving 4.91 63 810 9.59 polymer 4

Other embodiments are in the claims.

What is claimed is:
 1. An article, comprising: a first electrode, asecond electrode, and a photoactive material disposed between the firstand second electrodes, the photoactive material comprising a polymerincluding first and second comonomer repeat units, wherein the firstcomonomer repeat unit comprises a phenyl moiety substituted with 2-4halo groups or 2-4 C₁-C₄ trihaloalkyl groups; the second comonomerrepeat unit comprises a benzodithiophene moiety, a cyclopentadithiazolemoiety, a benzothiadiazole moiety, a thiadiazoloquinoxaline moiety, abenzoisothiazole moiety, a benzothiazole moiety, a dibenzosilole moiety,a thienothiophene moiety, a carbazole moiety, a dithienothiophenemoiety, a tetrahydroisoindole moiety, a fluorene moiety, a silolemoiety, a cyclopentadithiophene moiety, a thiazole moiety, athiazolothiazole moiety, a naphthothiadiazole moiety, a thienopyrazinemoiety, a silacyclopentadithiophene moiety, an oxazole moiety, animidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, or a benzotriazole moiety; and the articleis configured as a photovoltaic cell.
 2. The article of claim 1, whereinthe first comonomer repeat unit comprises a phenyl moiety of formula(1):

in which each of R₁, R₂, R₃, and R₄, independently, is H, halo, or C₁-C₄trihaloalkyl, provided that at least two of R₁, R₂, R₃, and R₄ is haloor C₁-C₄ trihaloalkyl.
 3. The article of claim 2, wherein each of R₁,R₂, R₃, and R₄, independently, is halo.
 4. The article of claim 2,wherein each of R₁, R₂, R₃, and R₄ is fluoro.
 5. The article of claim 1,wherein the second comonomer repeat unit comprises a benzodithiophenemoiety of formula (2), a benzodithiophene moiety of formula (3), acyclopentadithiazole moiety of formula (4), a benzothiadiazole moiety offormula (5), a thiadiazoloquinoxaline moiety of formula (6), abenzoisothiazole moiety of formula (7), a benzothiazole moiety offormula (8), a dibenzosilole moiety of formula (9), a thienothiophenemoiety of formula (10), a thienothiophene moiety of formula (11), acarbazole moiety of formula (12), a dithienothiophene moiety of formula(13), a tetrahydroisoindole moiety of formula (14), a fluorene moiety offormula (15), a silole moiety of formula (16), a cyclopentadithiophenemoiety of formula (17), a thiazole moiety of formula (18), athiazolothiazole moiety of formula (19), a naphthothiadiazole moiety offormula (20), a thienopyrazine moiety of formula (21), asilacyclopentadithiophene moiety of formula (22), an oxazole moiety offormula (23), an imidazole moiety of formula (24), a pyrimidine moietyof formula (25), a benzoxazole moiety of formula (26), a benzimidazolemoiety of formula (27), a pyridopyrazine moiety of formula (28), apyrazinopyridazine moiety of formula (29), a pyrazinoquinoxaline moietyof formula (30), a thiadiazolopyridine moiety of formula (31), athiadiazolopyridazine moiety of formula (32), a benzooxadiazole moietyof formula (33), an oxadiazolopyridine moiety of formula (34), anoxadiazolopyridazine moiety of formula (35), a benzoselenadiazole moietyof formula (36), a benzobisoxazole moiety of formula (37), abenzobisoxazole moiety of formula (38), a thienothiadiazole moiety offormula (39), a thienopyrroledione moiety of formula (40), a tetrazinemoiety of formula (41), a pyrrolopyrroledione moiety of formula (42), abenzotriazole moiety of formula (47), or a benzodithiophene moiety offormula (48):

wherein each of X and Y, independently, is CH₂, O, or S; each of R₅, R₆,R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy,aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR,COR, COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl.6. The article of claim 5, wherein the second comonomer repeat unitcomprises the benzodithiophene moiety of formula (2) or thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H, C₁-C₂₄ alkyl, or COOR.
 7. Thearticle of claim 6, wherein the second comonomer repeat unit comprisesthe benzodithiophene moiety of formula (2) or thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H, C₈H₁₇ alkyl, or COOC₁₂H₂₅.
 8. Thearticle of claim 1, wherein the polymer further comprises a thirdcomonomer repeat unit different from the first and second comonomerrepeat units, the third comonomer repeat unit comprises abenzodithiophene moiety, a cyclopentadithiazole moiety, abenzothiadiazole moiety, a thiadiazoloquinoxaline moiety, abenzoisothiazole moiety, a benzothiazole moiety, a dibenzosilole moiety,a thienothiophene moiety, a carbazole moiety, a dithienothiophenemoiety, a tetrahydroisoindole moiety, a fluorene moiety, a silolemoiety, a cyclopentadithiophene moiety, a thiazole moiety, athiazolothiazole moiety, a naphthothiadiazole moiety, a thienopyrazinemoiety, a silacyclopentadithiophene moiety, an oxazole moiety, animidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, a benzotriazole moiety, or afuran moiety.
 9. The article of claim 8, wherein the third comonomerrepeat unit comprises a benzodithiophene moiety of formula (2), abenzodithiophene moiety of formula (3), a cyclopentadithiazole moiety offormula (4), a benzothiadiazole moiety of formula (5), athiadiazoloquinoxaline moiety of formula (6), a benzoisothiazole moietyof formula (7), a benzothiazole moiety of formula (8), a dibenzosilolemoiety of formula (9), a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a carbazole moiety of formula(12), a dithienothiophene moiety of formula (13), a tetrahydroisoindolemoiety of formula (14), a fluorene moiety of formula (15), a silolemoiety of formula (16), a cyclopentadithiophene moiety of formula (17),a thiazole moiety of formula (18), a thiazolothiazole moiety of formula(19), a naphthothiadiazole moiety of formula (20), a thienopyrazinemoiety of formula (21), a silacyclopentadithiophene moiety of formula(22), an oxazole moiety of formula (23), an imidazole moiety of formula(24), a pyrimidine moiety of formula (25), a benzoxazole moiety offormula (26), a benzimidazole moiety of formula (27), a pyridopyrazinemoiety of formula (28), a pyrazinopyridazine moiety of formula (29), apyrazinoquinoxaline moiety of formula (30), a thiadiazolopyridine moietyof formula (31), a thiadiazolopyridazine moiety of formula (32), abenzooxadiazole moiety of formula (33), an oxadiazolopyridine moiety offormula (34), an oxadiazolopyridazine moiety of formula (35), abenzoselenadiazole moiety of formula (36), a benzobisoxazole moiety offormula (37), a benzobisoxazole moiety of formula (38), athienothiadiazole moiety of formula (39), a thienopyrroledione moiety offormula (40), a tetrazine moiety of formula (41), a pyrrolopyrroledionemoiety of formula (42), a thiophene moiety of formula (43), aselenophene moiety of formula (44), a thiadiazole moiety of formula(45), a quinoxaline moiety of formula (46), a benzotriazole moiety offormula (47), a benzodithiophene moiety of formula (48), or a furanmoiety of formula (49):

in which each of X and Y, independently, is CH₂, O, or S; each of R₅,R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy,aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR,COR, COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl.10. The article of claim 9, wherein the third comonomer repeat unitcomprises the benzothiadiazole moiety of formula (5) or thethiazolothiazole moiety of formula (19), in which each of R₅ and R₆ isH.
 11. The article of claim 8, wherein the polymer further comprises afourth comonomer repeat unit different from the first, second, and thirdcomonomer repeat units, the fourth comonomer repeat unit comprises athienothiophene moiety, a thiazole moiety, a thiazolothiazole moiety, athiophene moiety, a selenophene moiety, a thiadiazole moiety, or a furanmoiety.
 12. The article of claim 11, wherein the fourth comonomer repeatunit comprises a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a thiazole moiety of formula(18), a thiophene moiety of formula (43), a selenophene moiety offormula (44), a thiadiazole moiety of formula (45), or a furan moiety offormula (49):

wherein each of R₅ and R₆, independently, is H, halo, C₁-C₂₄ alkyl,C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, CN, OR, COR, COOR, or CON(RR′), in which each of R andR′, independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄cycloalkyl, or C₃-C₂₄ heterocycloalkyl.
 13. The article of claim 12,wherein the fourth comonomer repeat unit comprises the thiophene moietyof formula (43), in which each of R₅ and R₆, independently, is H, halo,or C₁-C₂₄ alkyl.
 14. The article of claim 13, wherein the fourthcomonomer repeat unit comprises the thiophene moiety of formula (43), inwhich each of R₅ and R₆, independently, is H, Cl, or C₁₄H₂₉.
 15. Anarticle, comprising: a first electrode, a second electrode, and aphotoactive material disposed between the first and second electrodes,the photoactive material comprising a polymer of formula (I):

wherein m is 0 or 1; each p, independently, is 0, 1, or 2; n is aninteger greater than 1; X is a phenyl moiety substituted with 2-4 halogroups or 2-4 C₁-C₄ trihaloalkyl groups; each D, independently, is abenzodithiophene moiety, a carbazole moiety, a fluorene moiety, acyclopentadithiophene moiety, or a silacyclopentadithiophene moiety; Ais a cyclopentadithiazole moiety, a benzothiadiazole moiety, athiadiazoloquinoxaline moiety, a benzoisothiazole moiety, abenzothiazole moiety, a thienothiophene moiety, a tetrahydroisoindolemoiety, a thiazole moiety, a thiazolothiazole moiety, anaphthothiadiazole moiety, a thienopyrazine moiety, an oxazole moiety,an imidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, a benzotriazole moiety, or afuran moiety; each T, independently, is a thienothiophene moiety, athiazole moiety, a thiophene moiety, a selenophene moiety, a thiadiazolemoiety, or a furan moiety; and the article is configured as aphotovoltaic cell.
 16. The article of claim 15, wherein X is a phenylmoiety of formula (1):

in which each of R₁, R₂, R₃, and R₄, independently, is H, halo, or C₁-C₄trihaloalkyl, provided that at least two of R₁, R₂, R₃, and R₄ is haloor C₁-C₄ trihaloalkyl; each D, independently, is a benzodithiophenemoiety of formula (2), a benzodithiophene moiety of formula (3), acarbazole moiety of formula (12), a fluorene moiety of formula (15), acyclopentadithiophene moiety of formula (17), asilacyclopentadithiophene moiety of formula (22), or a benzodithiophenemoiety of formula (48):

in which each of R₅, R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄alkyl, C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, OR, COR, COOR, or CON(RR′), in which each of R and R′,independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl,or C₃-C₂₄ heterocycloalkyl; and A is a cyclopentadithiazole moiety offormula (4), a benzothiadiazole moiety of formula (5), athiadiazoloquinoxaline moiety of formula (6), a benzoisothiazole moietyof formula (7), a benzothiazole moiety of formula (8), a thienothiophenemoiety of formula (10), a thienothiophene moiety of formula (11), atetrahydroisoindole moiety of formula (14), a thiazole moiety of formula(18), a thiazolothiazole moiety of formula (19), a naphthothiadiazolemoiety of formula (20), a thienopyrazine moiety of formula (21), anoxazole moiety of formula (23), an imidazole moiety of formula (24), apyrimidine moiety of formula (25), a benzoxazole moiety of formula (26),a benzimidazole moiety of formula (27), a pyridopyrazine moiety offormula (28), a pyrazinopyridazine moiety of formula (29), apyrazinoquinoxaline moiety of formula (30), a thiadiazolopyridine moietyof formula (31), a thiadiazolopyridazine moiety of formula (32), abenzooxadiazole moiety of formula (33), an oxadiazolopyridine moiety offormula (34), an oxadiazolopyridazine moiety of formula (35), abenzoselenadiazole moiety of formula (36), a benzobisoxazole moiety offormula (37), a benzobisoxazole moiety of formula (38), athienothiadiazole moiety of formula (39), a thienopyrroledione moiety offormula (40), a tetrazine moiety of formula (41), a pyrrolopyrroledionemoiety of formula (42), a thiophene moiety of formula (43), aselenophene moiety of formula (44), a thiadiazole moiety of formula(45), a quinoxaline moiety of formula (46), a benzotriazole moiety offormula (47), or a furan moiety of formula (49):

in which each of X and Y, independently, is CH₂, O, or S; each of R₅,R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy,aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR,COR, COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl;each T, independently, is a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a thiazole moiety of formula(18), a thiophene moiety of formula (43), a selenophene moiety offormula (44), a thiadiazole moiety of formula (45), or a furan moiety offormula (49):

wherein each of R₅ and R₆, independently, is H, halo, C₁-C₂₄ alkyl,C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, CN, OR, COR, COOR, or CON(RR′), in which each of R andR′, independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄cycloalkyl, or C₃-C₂₄ heterocycloalkyl.
 17. The article of claim 16,wherein m is 1, and each p is 0 or
 1. 18. The article of claim 17,wherein each of R₁, R₂, R₃, and R₄, independently, is halo.
 19. Thearticle of claim 18, wherein each of R₁, R₂, R₃, and R₄ is fluoro. 20.The article of claim 19, wherein each D, independently, is thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H or C₁-C₂₄ alkyl.
 21. The article ofclaim 20, wherein each D is the silacyclopentadithiophene moiety offormula (22), in which each of R₅ and R₆ is C₈H₁₇ alkyl, and each of R₇and R₈ is H.
 22. The article of claim 20, wherein A is thebenzothiadiazole moiety of formula (5) or the thiazolothiazole moiety offormula (19), in which each of R₅ and R₆ is H.
 23. The article of claim22, wherein the polymer is


24. The article of claim 22, wherein each p is 1 and each T,independently, is the thiophene moiety of formula (43), in which each ofR₅ and R₆, independently, is H, halo, or C₁-C₂₄ alkyl.
 25. The articleof claim 24, wherein each p is 1 and each T, independently, is thethiophene moiety of formula (43), in which each of R₅ and R₆,independently, is H, Cl, or C₁₄H₂₉ alkyl.
 26. The article of claim 25,wherein the polymer is


27. A polymer, comprising first and second comonomer repeat units,wherein the first comonomer repeat unit comprises a phenyl moietysubstituted with 2-4 halo groups or 2-4 C₁-C₄ trihaloalkyl groups; andthe second comonomer repeat unit comprises a benzodithiophene moiety, acyclopentadithiazole moiety, a benzothiadiazole moiety, athiadiazoloquinoxaline moiety, a benzoisothiazole moiety, abenzothiazole moiety, a dibenzosilole moiety, a thienothiophene moiety,a carbazole moiety, a dithienothiophene moiety, a tetrahydroisoindolemoiety, a fluorene moiety, a silole moiety, a cyclopentadithiophenemoiety, a thiazole moiety, a thiazolothiazole moiety, anaphthothiadiazole moiety, a thienopyrazine moiety, asilacyclopentadithiophene moiety, an oxazole moiety, an imidazolemoiety; a pyrimidine moiety, a benzoxazole moiety, a benzimidazolemoiety, a pyridopyrazine moiety, a pyrazinopyridazine moiety, apyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, or a benzotriazole moiety.
 28. The polymerof claim 27, wherein the first comonomer repeat unit comprises a phenylmoiety of formula (1):

in which each of R₁, R₂, R₃, and R₄, independently, is H, halo, or C₁-C₄trihaloalkyl, provided that at least two of R₁, R₂, R₃, and R₄ is haloor C₁-C₄ trihaloalkyl.
 29. The polymer of claim 28, wherein each of R₁,R₂, R₃, and R₄, independently, is halo.
 30. The polymer of claim 28,wherein each of R₁, R₂, R₃, and R₄ is fluoro.
 31. The polymer of claim27, wherein the second comonomer repeat unit comprises abenzodithiophene moiety of formula (2), a benzodithiophene moiety offormula (3), a cyclopentadithiazole moiety of formula (4), abenzothiadiazole moiety of formula (5), a thiadiazoloquinoxaline moietyof formula (6), a benzoisothiazole moiety of formula (7), abenzothiazole moiety of formula (8), a dibenzosilole moiety of formula(9), a thienothiophene moiety of formula (10), a thienothiophene moietyof formula (11), a carbazole moiety of formula (12), a dithienothiophenemoiety of formula (13), a tetrahydroisoindole moiety of formula (14), afluorene moiety of formula (15), a silole moiety of formula (16), acyclopentadithiophene moiety of formula (17), a thiazole moiety offormula (18), a thiazolothiazole moiety of formula (19), anaphthothiadiazole moiety of formula (20), a thienopyrazine moiety offormula (21), a silacyclopentadithiophene moiety of formula (22), anoxazole moiety of formula (23), an imidazole moiety of formula (24), apyrimidine moiety of formula (25), a benzoxazole moiety of formula (26),a benzimidazole moiety of formula (27), a pyridopyrazine moiety offormula (28), a pyrazinopyridazine moiety of formula (29), apyrazinoquinoxaline moiety of formula (30), a thiadiazolopyridine moietyof formula (31), a thiadiazolopyridazine moiety of formula (32), abenzooxadiazole moiety of formula (33), an oxadiazolopyridine moiety offormula (34), an oxadiazolopyridazine moiety of formula (35), abenzoselenadiazole moiety of formula (36), a benzobisoxazole moiety offormula (37), a benzobisoxazole moiety of formula (38), athienothiadiazole moiety of formula (39), a thienopyrroledione moiety offormula (40), a tetrazine moiety of formula (41), a pyrrolopyrroledionemoiety of formula (42), a benzotriazole moiety of formula (47), or abenzodithiophene moiety of formula (48):

wherein each of X and Y, independently, is CH₂, O, or S; each of R₅, R₆,R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy,aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR,COR, COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl.32. The polymer of claim 31, wherein the second comonomer repeat unitcomprises the benzodithiophene moiety of formula (2) or thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H, C₁-C₂₄ alkyl, or COOR.
 33. Thepolymer of claim 32, wherein the second comonomer repeat unit comprisesthe benzodithiophene moiety of formula (2) or thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H, C₈H₁₇ alkyl, or COOC₁₂H₂₅.
 34. Thepolymer of claim 27, wherein the polymer further comprises a thirdcomonomer repeat unit different from the first and second comonomerrepeat units, the third comonomer repeat unit comprises abenzodithiophene moiety, a cyclopentadithiazole moiety, abenzothiadiazole moiety, a thiadiazoloquinoxaline moiety, abenzoisothiazole moiety, a benzothiazole moiety, a dibenzosilole moiety,a thienothiophene moiety, a carbazole moiety, a dithienothiophenemoiety, a tetrahydroisoindole moiety, a fluorene moiety, a silolemoiety, a cyclopentadithiophene moiety, a thiazole moiety, athiazolothiazole moiety, a naphthothiadiazole moiety, a thienopyrazinemoiety, a silacyclopentadithiophene moiety, an oxazole moiety, animidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, a benzotriazole moiety, or afuran moiety.
 35. The polymer of claim 34, wherein the third comonomerrepeat unit comprises a benzodithiophene moiety of formula (2), abenzodithiophene moiety of formula (3), a cyclopentadithiazole moiety offormula (4), a benzothiadiazole moiety of formula (5), athiadiazoloquinoxaline moiety of formula (6), a benzoisothiazole moietyof formula (7), a benzothiazole moiety of formula (8), a dibenzosilolemoiety of formula (9), a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a carbazole moiety of formula(12), a dithienothiophene moiety of formula (13), a tetrahydroisoindolemoiety of formula (14), a fluorene moiety of formula (15), a silolemoiety of formula (16), a cyclopentadithiophene moiety of formula (17),a thiazole moiety of formula (18), a thiazolothiazole moiety of formula(19), a naphthothiadiazole moiety of formula (20), a thienopyrazinemoiety of formula (21), a silacyclopentadithiophene moiety of formula(22), an oxazole moiety of formula (23), an imidazole moiety of formula(24), a pyrimidine moiety of formula (25), a benzoxazole moiety offormula (26), a benzimidazole moiety of formula (27), a pyridopyrazinemoiety of formula (28), a pyrazinopyridazine moiety of formula (29), apyrazinoquinoxaline moiety of formula (30), a thiadiazolopyridine moietyof formula (31), a thiadiazolopyridazine moiety of formula (32), abenzooxadiazole moiety of formula (33), an oxadiazolopyridine moiety offormula (34), an oxadiazolopyridazine moiety of formula (35), abenzoselenadiazole moiety of formula (36), a benzobisoxazole moiety offormula (37), a benzobisoxazole moiety of formula (38), athienothiadiazole moiety of formula (39), a thienopyrroledione moiety offormula (40), a tetrazine moiety of formula (41), a pyrrolopyrroledionemoiety of formula (42), a thiophene moiety of formula (43), aselenophene moiety of formula (44), a thiadiazole moiety of formula(45), a quinoxaline moiety of formula (46), a benzotriazole moiety offormula (47), a benzodithiophene moiety of formula (48), or a furanmoiety of formula (49):

in which each of X and Y, independently, is CH₂, O, or S; each of R₅,R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy,aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR,COR, COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl.36. The polymer of claim 35, wherein the third comonomer repeat unitcomprises the benzothiadiazole moiety of formula (5) or thethiazolothiazole moiety of formula (19), in which each of R₅ and R₆ isH.
 37. The polymer of claim 34, wherein the polymer further comprises afourth comonomer repeat unit different from the first, second, and thirdcomonomer repeat units, the fourth comonomer repeat unit comprises athienothiophene moiety, a thiazole moiety, a thiazolothiazole moiety, athiophene moiety, a selenophene moiety, a thiadiazole moiety, or a furanmoiety.
 38. The polymer of claim 37, wherein the fourth comonomer repeatunit comprises a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a thiazole moiety of formula(18), a thiophene moiety of formula (43), a selenophene moiety offormula (44), a thiadiazole moiety of formula (45), or a furan moiety offormula (49):

wherein each of R₅ and R₆, independently, is H, halo, C₁-C₂₄ alkyl,C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, CN, OR, COR, COOR, or CON(RR′), in which each of R andR′, independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄cycloalkyl, or C₃-C₂₄ heterocycloalkyl.
 39. The polymer of claim 38,wherein the fourth comonomer repeat unit comprises the thiophene moietyof formula (43), in which each of R₅ and R₆, independently, is H, halo,or C₁-C₂₄ alkyl.
 40. The polymer of claim 39, wherein the fourthcomonomer repeat unit comprises the thiophene moiety of formula (43), inwhich each of R₅ and R₆, independently, is H, Cl, or C₁₄H₂₉.
 41. Apolymer of formula (I):

wherein m is 0 or 1; each p, independently, is 0, 1, or 2; n is aninteger greater than 1; X is a phenyl moiety substituted with 2-4 halogroups or 2-4 C₁-C₄ trihaloalkyl groups; each D, independently, is abenzodithiophene moiety, a carbazole moiety, a fluorene moiety, acyclopentadithiophene moiety, or a silacyclopentadithiophene moiety; Ais a cyclopentadithiazole moiety, a benzothiadiazole moiety, athiadiazoloquinoxaline moiety, a benzoisothiazole moiety, abenzothiazole moiety, a thienothiophene moiety, a tetrahydroisoindolemoiety, a thiazole moiety, a thiazolothiazole moiety, anaphthothiadiazole moiety, a thienopyrazine moiety, an oxazole moiety,an imidazole moiety, a pyrimidine moiety, a benzoxazole moiety, abenzimidazole moiety, a pyridopyrazine moiety, a pyrazinopyridazinemoiety, a pyrazinoquinoxaline moiety, a thiadiazolopyridine moiety, athiadiazolopyridazine moiety, a benzooxadiazole moiety, anoxadiazolopyridine moiety, an oxadiazolopyridazine moiety, abenzoselenadiazole moiety, a benzobisoxazole moiety, a thienothiadiazolemoiety, a thienopyrroledione moiety, a tetrazine moiety, apyrrolopyrroledione moiety, a thiophene moiety, a selenophene moiety, athiadiazole moiety, a quinoxaline moiety, a benzotriazole moiety, or afuran moiety; and each T, independently, is a thienothiophene moiety, athiazole moiety, a thiophene moiety, a selenophene moiety, a thiadiazolemoiety, or a furan moiety.
 42. The polymer of claim 41, wherein X is aphenyl moiety of formula (1):

in which each of R₁, R₂, R₃, and R₄, independently, is H, halo, or C₁-C₄trihaloalkyl, provided that at least two of R₁, R₂, R₃, and R₄ is haloor C₁-C₄ trihaloalkyl; each D, independently, is a benzodithiophenemoiety of formula (2), a benzodithiophene moiety of formula (3), acarbazole moiety of formula (12), a fluorene moiety of formula (15), acyclopentadithiophene moiety of formula (17), asilacyclopentadithiophene moiety of formula (22), or a benzodithiophenemoiety of formula (48):

in which each of R₅, R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄alkyl, C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, CN, OR, COR, COOR, or CON(RR′), in which each of R andR′, independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄cycloalkyl, or C₃-C₂₄ heterocycloalkyl; and A is a cyclopentadithiazolemoiety of formula (4), a benzothiadiazole moiety of formula (5), athiadiazoloquinoxaline moiety of formula (6), a benzoisothiazole moietyof formula (7), a benzothiazole moiety of formula (8), a thienothiophenemoiety of formula (10), a thienothiophene moiety of formula (11), atetrahydroisoindole moiety of formula (14), a thiazole moiety of formula(18), a thiazolothiazole moiety of formula (19), a naphthothiadiazolemoiety of formula (20), a thienopyrazine moiety of formula (21), anoxazole moiety of formula (23), an imidazole moiety of formula (24), apyrimidine moiety of formula (25), a benzoxazole moiety of formula (26),a benzimidazole moiety of formula (27), a pyridopyrazine moiety offormula (28), a pyrazinopyridazine moiety of formula (29), apyrazinoquinoxaline moiety of formula (30), a thiadiazolopyridine moietyof formula (31), a thiadiazolopyridazine moiety of formula (32), abenzooxadiazole moiety of formula (33), an oxadiazolopyridine moiety offormula (34), an oxadiazolopyridazine moiety of formula (35), abenzoselenadiazole moiety of formula (36), a benzobisoxazole moiety offormula (37), a benzobisoxazole moiety of formula (38), athienothiadiazole moiety of formula (39), a thienopyrroledione moiety offormula (40), a tetrazine moiety of formula (41), a pyrrolopyrroledionemoiety of formula (42), a thiophene moiety of formula (43), aselenophene moiety of formula (44), a thiadiazole moiety of formula(45), a quinoxaline moiety of formula (46), a benzotriazole moiety offormula (47), or a furan moiety of formula (49):

in which each of X and Y, independently, is CH₂, O, or S; each of R₅,R₆, R₇, and R₈, independently, is H, halo, C₁-C₂₄ alkyl, C₁-C₂₄ alkoxy,aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄ heterocycloalkyl, CN, OR,COR, COOR, or CON(RR′), in which each of R and R′, independently, is H,C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄heterocycloalkyl; and each of R₉ and R₁₀, independently, is H, C₁-C₂₄alkyl, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, or C₃-C₂₄ heterocycloalkyl;each T, independently, is a thienothiophene moiety of formula (10), athienothiophene moiety of formula (11), a thiazole moiety of formula(18), a thiophene moiety of formula (43), a selenophene moiety offormula (44), a thiadiazole moiety of formula (45), or a furan moiety offormula (49):

wherein each of R₅ and R₆, independently, is H, halo, C₁-C₂₄ alkyl,C₁-C₂₄ alkoxy, aryl, heteroaryl, C₃-C₂₄ cycloalkyl, C₃-C₂₄heterocycloalkyl, CN, OR, COR, COOR, or CON(RR′), in which each of R andR′, independently, is H, C₁-C₂₄ alkyl, aryl, heteroaryl, C₃-C₂₄cycloalkyl, or C₃-C₂₄ heterocycloalkyl.
 43. The polymer of claim 42,wherein m is 1, and each p is 0 or
 1. 44. The polymer of claim 43,wherein each of R₁, R₂, R₃, and R₄, independently, is halo.
 45. Thepolymer of claim 44, wherein each of R₁, R₂, R₃, and R₄ is fluoro. 46.The polymer of claim 45, wherein each D, independently, is thesilacyclopentadithiophene moiety of formula (22), in which each of R₅,R₆, R₇, and R₈, independently, is H or C₁-C₂₄ alkyl.
 47. The polymer ofclaim 46, wherein each D is the silacyclopentadithiophene moiety offormula (22), in which each of R₅ and R₆ is C₈H₁₇ alkyl, and each of R₇and R₈ is H.
 48. The polymer of claim 46, wherein A is thebenzothiadiazole moiety of formula (5) or the thiazolothiazole moiety offormula (19), in which each of R₅ and R₆ is H.
 49. The polymer of claim48, wherein the polymer is


50. The polymer of claim 48, wherein each p is 1 and each T,independently, is the thiophene moiety of formula (43), in which each ofR₅ and R₆, independently, is H, halo, or C₁-C₂₄ alkyl.
 51. The polymerof claim 50, wherein each p is 1 and each T, independently, is thethiophene moiety of formula (43), in which each of R₅ and R₆,independently, is H, Cl, or C₁₄H₂₉ alkyl.
 52. The polymer of claim 51,wherein the polymer is